iPierian

Acquired

Bristol Myers Squibb - Global Biopharmaceutical Company

South San Francisco, United States · Founded 2008

Employees
11–50
Founded
2008
Business Model
B2B
Last Round
Series CSep 2013
Rounds
3
Acquired by
Bristol-Myers Squibb CompanyApr 2014

About

iPierian (formerly iZumi Bio) was a South San Francisco biopharmaceutical company founded in 2008 that pioneered the use of induced pluripotent stem cell (iPSC) technology to model and develop therapies for neurodegenerative diseases, including ALS and tauopathies. The company was acquired by Bristol-Myers Squibb in 2014 for up to $725 million.

Summary

iPierian is a Biotech company based in South San Francisco, United States, founded in 2008. Its most recent funding was a Series C round in Sep 2013. Investors include SR One, Kleiner Perkins and MPM Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionApr 2014

Sign up to see all 4 rounds

Series B through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

iPierian on Indexed.vc
<a href="https://indexed.vc/companies/ipierian"><img src="https://indexed.vc/api/badge/company/ipierian" alt="iPierian on Indexed.vc" width="260" height="76" /></a>